Hepatitis C Virus Infection Is Inhibited by a Noncanonical Antiviral Signaling Pathway Targeted by NS3-NS4A
- 1 December 2019
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 93 (23)
Abstract
The HCV NS3-NS4A protease complex facilitates viral replication by cleaving and inactivating the antiviral innate immune signaling proteins MAVS and Riplet, which are essential for RIG-I activation. NS3-NS4A therefore prevents IRF3 activation and interferon induction during HCV infection. Here, we uncover an amino acid residue within the NS4A transmembrane domain that is essential for inactivation of Riplet but does not affect MAVS cleavage by NS3-NS4A. Our study reveals that Riplet is involved in a RIG-I- and MAVS-independent signaling pathway that activates IRF3 and that this pathway is normally inactivated by NS3-NS4A during HCV infection. Our study selectively uncouples these distinct regulatory mechanisms within NS3-NS4A and defines a new role for Riplet in the antiviral response to HCV. Since Riplet is known to be inhibited by other RNA viruses, such as such influenza A virus, this innate immune signaling pathway may also be important in controlling other RNA virus infections.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of Allergy and Infectious Diseases (K22AI100935)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (R21AI124100)
- Burroughs Wellcome Fund (1016810)
- Ford Foundation
This publication has 58 references indexed in Scilit:
- Fiji: an open-source platform for biological-image analysisNature Methods, 2012
- Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complexProceedings of the National Academy of Sciences, 2008
- Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNANature, 2008
- TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activityNature, 2007
- Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2Proceedings of the National Academy of Sciences, 2007
- Viral and therapeutic control of IFN-β promoter stimulator 1 during hepatitis C virus infectionProceedings of the National Academy of Sciences, 2006
- Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virusNature, 2005
- The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responsesNature Immunology, 2004
- Interfacial Anchor Properties of Tryptophan Residues in Transmembrane Peptides Can Dominate over Hydrophobic Matching Effects in Peptide−Lipid InteractionsBiochemistry, 2003
- The Aromatic Residues Trp and Phe Have Different Effects on the Positioning of a Transmembrane Helix in the Microsomal MembraneBiochemistry, 1999